Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 73651-73700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06043986
Would Artificial Intelligence Reduce Delays to Nurse Response Times
N/ARecruiting
40 participants
Started: May 23, 2023 · Completed: Sep 2, 2024
1 condition1 sponsor1 location
NCT05926336
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
PHASE4Recruiting
1,316 participants
Started: May 23, 2023 · Completed: Jul 31, 2026
4 conditions1 sponsor1 location
NCT05951088
Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)
N/ARecruiting
200 participants
Started: May 23, 2023 · Completed: May 30, 2026
3 conditions1 sponsor1 location
NCT05973578
Cardiac RadiothErapy for VEntricular Tachycardia
NARecruiting
5 participants
Started: May 23, 2023 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT05868174
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
PHASE1Recruiting
36 participants
Started: May 23, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors5 locations
NCT05609448
MRI-guided Holmium-166 Radioembolization
NAEnrolling by invitation
15 participants
Started: May 23, 2023 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT06476860
Proteinuria During Sepsis and Septic Shock: Characterization and Association With ARDS
N/AActive, not recruiting
100 participants
Started: May 23, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05540938
Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
PHASE4Recruiting
340 participants
Started: May 23, 2023 · Completed: Mar 31, 2026
1 condition6 sponsors1 location
NCT05794958
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
PHASE1Recruiting
20 participants
Started: May 23, 2023 · Completed: Apr 1, 2038
2 conditions2 sponsors1 location
NCT05609552
Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
N/ARecruiting
20 participants
Started: May 22, 2023 · Completed: Feb 1, 2027
1 condition2 sponsors1 location
NCT06047561
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
N/ARecruiting
300 participants
Started: May 22, 2023 · Completed: May 22, 2028
1 condition1 sponsor1 location
NCT05784545
Dietary Supplementation With Blueberry in OA
NAActive, not recruiting
58 participants
Started: May 22, 2023 · Completed: Sep 1, 2027
1 condition3 sponsors1 location
NCT05599022
Randomized Assessment of TcMS for VT Storm
NARecruiting
60 participants
Started: May 22, 2023 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT05884333
Cord Blood Transplant in Adults With Blood Cancers
PHASE2Recruiting
54 participants
Started: May 22, 2023 · Completed: May 22, 2028
6 conditions1 sponsor1 location
NCT06332625
The Fingerprinting of Inherited Leukoencephalopathies: A New Brain Imaging, Genetic and Clinical Assessment
N/ARecruiting
100 participants
Started: May 22, 2023 · Completed: Nov 22, 2025
1 condition4 sponsors3 locations
NCT05798455
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma
PHASE1/PHASE2Not yet recruiting
30 participants
Started: May 22, 2023 · Completed: May 22, 2026
1 condition1 sponsor1 location
NCT05922176
Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis
N/ARecruiting
30 participants
Started: May 22, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05653687
Total Hip Arthroplasty: Fluoroscopy vs Freehand
NARecruiting
84 participants
Started: May 22, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05823116
Continuous vs. Intermittent Infusion Vancomycin
PHASE4Recruiting
56 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04990102
Phase IB/II of CPX-351 for Relapse Prevention in AML
PHASE1/PHASE2Recruiting
24 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT05619913
EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma
PHASE2Recruiting
30 participants
Started: May 22, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors6 locations
NCT05681624
Maternal Oxygen Supplementation for Intrauterine Resuscitation
NARecruiting
2,124 participants
Started: May 22, 2023 · Completed: Aug 1, 2028
3 conditions7 sponsors1 location
NCT05737121
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
PHASE2Recruiting
120 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors14 locations
NCT05411094
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer
PHASE1Recruiting
18 participants
Started: May 22, 2023 · Completed: Jul 1, 2028
4 conditions1 sponsor11 locations
NCT04972942
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma
PHASE1Recruiting
30 participants
Started: May 22, 2023 · Completed: Sep 30, 2028
2 conditions1 sponsor16 locations
NCT06320158
Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly
N/ARecruiting
1,108 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06307171
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
NARecruiting
170 participants
Started: May 22, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05997095
Post-operative Electrical Muscle Stimulation to Stimulate Muscle Protein Synthesis in Humans
NAActive, not recruiting
10 participants
Started: May 22, 2023 · Completed: Dec 28, 2025
1 condition1 sponsor1 location
NCT05599412
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
N/ARecruiting
600 participants
Started: May 22, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06776042
Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
NARecruiting
140 participants
Started: May 22, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05820932
Predicting Cognitive Decline From Androgen Deprivation Therapy
N/ARecruiting
240 participants
Started: May 22, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05943210
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
NARecruiting
25 participants
Started: May 22, 2023 · Completed: May 31, 2028
1 condition2 sponsors5 locations
NCT05747794
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy
PHASE2/PHASE3Active, not recruiting
849 participants
Started: May 22, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor22 locations
NCT05293626
Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations
PHASE1/PHASE2Active, not recruiting
12 participants
Started: May 22, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor3 locations
NCT05735327
A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY
N/ARecruiting
50 participants
Started: May 22, 2023 · Completed: Jun 1, 2027
1 condition1 sponsor12 locations
NCT05849740
An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A
PHASE4Recruiting
25 participants
Started: May 22, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT07122466
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
N/AActive, not recruiting
24 participants
Started: May 22, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05318027
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
PHASE2Recruiting
70 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06136949
The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study
N/ARecruiting
150 participants
Started: May 22, 2023 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT06167642
Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab
N/AEnrolling by invitation
75 participants
Started: May 22, 2023 · Completed: Mar 31, 2027
4 conditions2 sponsors1 location
NCT06337461
Computational MOdelliNg of MyoCardial PERfusion to Improve OuTcome Prediction Based on COronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography
N/ARecruiting
400 participants
Started: May 22, 2023 · Completed: May 30, 2025
1 condition3 sponsors1 location
NCT05869032
Normative QEEG/ERP Data for Healthy Volunteers
N/ARecruiting
80 participants
Started: May 22, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05065840
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
NARecruiting
365 participants
Started: May 22, 2023 · Completed: Jun 1, 2027
2 conditions2 sponsors4 locations
NCT06103890
Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
N/ARecruiting
100 participants
Started: May 22, 2023 · Completed: Jul 31, 2025
1 condition3 sponsors1 location
NCT05916378
Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies
N/AActive, not recruiting
150 participants
Started: May 22, 2023 · Completed: Mar 30, 2025
1 condition2 sponsors1 location
NCT05972954
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
PHASE2Active, not recruiting
32 participants
Started: May 22, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor9 locations
NCT05855980
Toe Amputations in Patients With Diabetes
NARecruiting
102 participants
Started: May 22, 2023 · Completed: May 1, 2025
3 conditions1 sponsor1 location
NCT06542627
Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study
NARecruiting
420 participants
Started: May 22, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06017141
Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
PHASE2Recruiting
80 participants
Started: May 22, 2023 · Completed: May 22, 2026
1 condition2 sponsors1 location
NCT06111833
Optimized Diagnosis and Precision Medicine of MODY
N/ARecruiting
1,500 participants
Started: May 22, 2023 · Completed: May 21, 2028
3 conditions2 sponsors1 location